NURSING

NAME ACTION INDICATIONS ROUTE & DOSE CONTRAINDICATIONS ADVERSE EFFECT

CONSIDERATIONS

Generic Name: Increases motor To prevent band IV: 0.2 mg over Contraindicated in: CNS: dizziness,  Monitor and
 Methylergonovine activity of the treat postpartum 1minute while  Pregnant patient headache, seizures, record the blood
maleate uterus by direct hemorrhage hallucinations, CVA pressure, pulse
monitoring blood
stimulation of the caused by  Patient sensitive with IV use. rate, and uterine
smooth muscle, uterine agony or pressure and
to ergot response; report
Brand Name: shortening the subinvolution. uterine preparations CV: hypertension, sudden change in
 Methergine third stage of labor contractions. transient chest pain, vital signs,
and reducing blood  Hypertensive palpitations, frequent periods
loss. IM: 0.2 mg q 2 patient or hypotension, of uterine
to4 hours to a toxemia thrombophlebitis relaxation, and
maximum of 5 character and
EENT: tinnitus, nasal amount of
doses. For
congestion vaginal bleeding.
excessive uterine
 Monitor
bleeding or other GI: nausea, vomiting, contractions,
emergencies. diarrhea, foul taste which may begin
immediately.
* GU: hematuria Contractions may
continue for up
MUSCULOSKELETAL: to 45 minutes
Leg cramps after IV use or for
3 hours or more
RESPIRATORY: after P.O or IM
dyspnea use.
 Store tablets in
SKIN: diaphoresis tightly closed,
light-resistant
container.
Discard if
discolored.
 CONTRAINDICATIO NURSING
NAME ACTION INDICATIONS ROUTE & DOSE ADVERSE EFFECT
NS CONSIDERATIONS

Generic Name: Hormone that  To induce IV: “10-40” u in Contraindicated: MATERNAL  Monitor and record
 Oxytocin causes potent or 1000 ml of D5W  In patients CNS: subarachnoid uterine contractions,
and selective stimulate injection, LR or hypertensive to hemorrhage, seizures, coma heart rate, BP,
stimulation of labor NSS. IV rate drug. CV: hypertension; increased intrauterine
Brand Name: uterine and sufficient to heart rate, systemic venous pressure, FHR, and
 Pitocin mammary gland control uterine  When vaginal return, and cardiac output; character of blood
smooth muscle.  To reduce atony. delivery isn’t arrhythmias loss q 15 min.
postpartum advised (placenta GI: nausea and vomiting  Monitor fluid I&O.
bleeding IM: “10” u after previa, vasa GU: titanic uterine Antidiuretic effect
after the delivery of previa, invasive contractions, may lead to fluid
expulsion placenta cervical abruptioplacentae, impaired overload, seizures,
of placenta carcinoma, uterine blood flow, pelvic and coma from
genital herpes), hematoma, increased uterine water intoxication.
when CPD is motility, uterine rupture,  Have 20%
 Incomplete present or when postpartum hemorrhage magnesium
or delivery requires HEMATOLOGIC: afibrigonemia sulfatesolution
inevitable conversion, as in possibly related to postpartum available to relax the
abortion transverse lie. bleeding myometrium
OTHER: hypersensitivity  If contractions are
reactions, anaphylaxis, death less than 2 min.
 In fetal distress from oxytocin-induced water apart, if they’re
when delivery intoxication above 50mm Hg, or
isn’t imminent, in if they last 90sec. or
prematurity, in FETAL longer, stop
other obstetric CNS: infant brain damage infusion, and turn
emergencies, and CV: bradycardia, PVCs, patient on her side,
in patient with arrhythmias and notify prescriber
severe toxemia EENT: neonatal retinal  Never give oxytocin
or hypertonic hemorrhage simultaneously by
uterine patterns. HEPATIC: neonatal jaundice more than one
RESPIRATORY: anoxia, route.
asphyxia  Be alert of adverse
OTHER: low APGAR score @ 5 reactions.
minutes
 NURSING
NAME ACTION INDICATIONS ROUTE & DOSE CONTRAINDICATIONS ADVERSE EFFECT
CONSIDERATIONS

Generic Name: Second-generation  Serious LRTI, IV: 0.2 mg over Contraindicated in: CNS: dizziness,  Monitor and
 Cefuroxime cephalosporin that UTIs, skin and 1minute while  Pregnant patient headache, seizures, record the blood
Sodium inhibits cell-wall skin structure  Patient sensitive hallucinations, CVA pressure, pulse
monitoring blood
synthesis infections, to ergot with IV use. rate, and uterine
promoting osmotic pressure and
bone and joint preparations response; report
Brand Name: instability; usually infections uterine  Hypertensive CV: hypertension, sudden change in
 Zinacef bactericidal. contractions. patient transient chest pain, vital signs,
 Toxemia palpitations, frequent periods
IM: 0.2 mg q 2 hypotension, of uterine
to4 hours to a thrombophlebitis relaxation, and
maximum of 5 character and
EENT: tinnitus, nasal amount of
doses. For
congestion vaginal bleeding.
excessive uterine
 Monitor
bleeding or other GI: nausea, vomiting, contractions,
emergencies. diarrhea, foul taste which may begin
immediately.
* GU: hematuria Contractions may
continue for up
MUSCULOSKELETAL: to 45 minutes
Leg cramps after IV use or for
3 hours or more
RESPIRATORY: after P.O or IM
dyspnea use.
 Store tablets in
SKIN: diaphoresis tightly closed,
light-resistant
container.
Discard if
discolored.